No Data
No Data
Huakang Medical (301235.SZ) won the bid for 776.8874 million yuan laboratory process project in Dalian Yinggeishi Science City
Huakang Medical (301235.SZ) issued an announcement. On May 24, 2024, the company received a bidding agency...
Huakang Medical (301235.SZ): Notice of winning bid received
Gelonghui, May 24, 丨 Huakang Medical (301235.SZ) announced that the company disclosed the “Prompt Notice on Pre-winning the Project” on April 29, 2024. On May 24, 2024, the company received the “Notice of Winning Bid” issued by the bidding agency Dalian Electromechanical Equipment Bidding Co., Ltd., confirming that the company was the winning supplier for the “Dalian Yingge Stone Science City Laboratory Process Project (Phase 1) Construction Section 1 (A1-03, 17, 18, A3-11 plot)” project, with a bid price of 77,687,437.41 yuan.
Huakang Medical (301235.SZ) plans to pay 1 yuan for 10 shares to be deducted from interest on May 30
Huakang Medical (301235.SZ) announced that the company's 2023 equity distribution plan: 1 yuan (tax included) for every 10 shares to all shareholders; the exclusion date is: May 30, 2024.
Express News | Huakang Medical: Won the bid for the 81.3689 million yuan Chongqing Fourth People's Hospital Science City Campus Construction Project Medical Special Project
Review of Huakang Medical (301235) 2023 Report and 2024 First Quarter Report: Focus on the two main and three components to set a benchmark in the medical purification industry
Event: Huakang Medical recently released reports for the first quarter of 2023 and 2024: In 2023, the company achieved revenue of 1.60 billion yuan (+34.7%), mainly from medical purification system integration business and medical consumables sales
Huakang Medical (301235.SZ): Medical purification system integration business application scenarios include special departments such as operating departments, ICU, disinfection supply centers, medical laboratories, negative pressure isolation wards, etc.
Gelonghui, May 10 | Huakang Medical (301235.SZ) said on the investor interactive platform that the company's medical purification system integration business application scenarios include special departments such as operating departments, ICU, disinfection supply centers, medical laboratories, reproductive pregnancy assistance centers, laminar flow wards, static distribution centers, and negative pressure isolation wards. In the future, the company will continue to focus on “integrated medical and laboratory integrated solutions”, with “smart medical integrated services, overall after-sales operation and maintenance hosting for medical special projects, medical device R&D, production, sales, and storage, sales, and third party distribution of medical consumables” as the main focus.
No Data